✦ LIBER ✦

Preface. Major issues and future prospects in the delivery of therapeutic and diagnostic agents to the respiratory tract

✍ Scribed by Igor Gonda

Book ID: 113291727
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 585 KB
Volume: 5
Category: Article
ISSN: 0169-409X
DOI: 10.1016/0169-409x(90)90003-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The diagnostic and therapeutic difficult

The diagnostic and therapeutic difficulties of the recurrent lower respiratory tract infections in children with neurological disorders

✍ Jamroz, Ewa; Kordys-Darmolińska, Bożena; Głuszkiewicz, Ewa; Woś, Halina 📂 Article 📅 2011 🏛 Elsevier 🌐 Polish ⚖ 217 KB

Polymeric nanocarriers for controlled an

Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS

✍ Gagliardi, Mariacristina; Bardi, Giuseppe; Bifone, Angelo 📂 Article 📅 2012 🏛 Future Science 🌐 English ⚖ 693 KB

In silico models of aerosol delivery to

In silico models of aerosol delivery to the respiratory tract — Development and applications

✍ P. Worth Longest; Landon T. Holbrook 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 921 KB

The circulation of the airways: anatomy,

The circulation of the airways: anatomy, physiology and potential role in drug delivery to the respiratory tract

✍ Alejandro D. Chediak; Adam Wanner 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 438 KB

Subcutaneous and intravenous delivery of

Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography

✍ S.M. Moghimi; B. Bonnemain 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 353 KB

[Advances in Delivery Science and Techno

[Advances in Delivery Science and Technology] RNA Interference from Biology to Therapeutics || The Application of MicroRNAs in Cancer Diagnostics

✍ Howard, Kenneth A. 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 895 KB

The enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a key determinant in realizing the full clinical potential of